Phio Pharmaceuticals Corp (NASDAQ: PHIO) open the trading on Thursday, with a bit cautious approach as it glided -30.68% to $1.74, before settling in for the price of $2.51 at the close. Taking a more long-term approach, PHIO posted a 52-week range of $2.17-$10.35.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -36.96%. Meanwhile, its Annual Earning per share during the time was 62.38%. This publicly-traded company’s shares outstanding now amounts to $1.06 million, simultaneously with a float of $1.02 million. The organization now has a market capitalization sitting at $1.84 million. At the time of writing, stock’s 50-day Moving Average stood at $2.77, while the 200-day Moving Average is $4.65.
Phio Pharmaceuticals Corp (PHIO) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Phio Pharmaceuticals Corp’s current insider ownership accounts for 3.05%, in contrast to 2.70% institutional ownership. According to the most recent insider trade that took place on Jun 07 ’24, this organization’s President & CEO bought 1,000 shares at the rate of 0.74, making the entire transaction reach 740 in total value, affecting insider ownership by 20,990. Preceding that transaction, on Jun 06 ’24, Company’s President & CEO bought 1,000 for 0.75, making the whole transaction’s value amount to 750. This particular insider is now the holder of 19,990 in total.
Phio Pharmaceuticals Corp (NASDAQ: PHIO) Trading Performance Indicators
Let’s observe the current performance indicators for Phio Pharmaceuticals Corp (PHIO). It’s Quick Ratio in the last reported quarter now stands at 6.38. The Stock has managed to achieve an average true range (ATR) of 0.34.
In the same vein, PHIO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -13.94.
Technical Analysis of Phio Pharmaceuticals Corp (PHIO)
[Phio Pharmaceuticals Corp, PHIO] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 12.45% While, its Average True Range was 0.38.
Raw Stochastic average of Phio Pharmaceuticals Corp (PHIO) in the period of the previous 100 days is set at 8.50%, which indicates a major fall in contrast to 13.31% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 165.09% that was higher than 110.53% volatility it exhibited in the past 100-days period.
